BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6798670)

  • 1. [Progress in viral hepatitis].
    Soulier JP; Courouce AM
    Rev Fr Transfus Immunohematol; 1981 Nov; 24(5):501-17. PubMed ID: 6798670
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B vaccine: current progress and strategies for utilization.
    Maynard JE
    Prog Clin Biol Res; 1980; 47():157-68. PubMed ID: 7208509
    [No Abstract]   [Full Text] [Related]  

  • 3. Viral markers of hepatitis.
    Velasco M
    Lab Res Methods Biol Med; 1983; 7():103-17. PubMed ID: 6413796
    [No Abstract]   [Full Text] [Related]  

  • 4. Viral Hepatitis: a review.
    Neimark S; Rogers AI
    Am J Gastroenterol; 1982 Jun; 77(6):431-5. PubMed ID: 6283881
    [No Abstract]   [Full Text] [Related]  

  • 5. [What should a vaccine against hepatitis B be like?].
    Anan'ev VA; Zhdanov VM
    Vopr Virusol; 1978; (6):643-9. PubMed ID: 86238
    [No Abstract]   [Full Text] [Related]  

  • 6. [Various forms of hepatitis].
    Magyar I
    Orv Hetil; 1982 Mar; 123(10):579-82. PubMed ID: 6803215
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current status of the problem of viral hepatitis B prophylaxis].
    Golosova TV; Vlasikhina EM
    Probl Gematol Pereliv Krovi; 1980 Sep; 25(9):49-55. PubMed ID: 6999496
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum immunoglobulin levels in acute viral hepatitis, HB Ag carrier mothers, and their new borns.
    Mehrotra R; Srivastava S; Srivastava VK; Mehrotra S
    Indian J Pathol Microbiol; 1988 Jan; 31(1):42-9. PubMed ID: 3133315
    [No Abstract]   [Full Text] [Related]  

  • 9. Serologic evaluation of viral hepatitis.
    Hollinger FB
    Hosp Pract (Off Ed); 1987 Feb; 22(2):101-14. PubMed ID: 3100558
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis prophylaxis.
    Aach RD
    Johns Hopkins Med J; 1982 Dec; 151(6):318-25. PubMed ID: 6184517
    [No Abstract]   [Full Text] [Related]  

  • 11. Advances in viral hepatitis. Report of the WHO Expert Committee on Viral Hepatitis.
    World Health Organ Tech Rep Ser; 1977; (602):1-62. PubMed ID: 193307
    [No Abstract]   [Full Text] [Related]  

  • 12. Current concepts in viral hepatitis.
    Hoofnagle JH
    Arq Gastroenterol; 1979; 16(3):124-32. PubMed ID: 94994
    [No Abstract]   [Full Text] [Related]  

  • 13. The hepatitis B vaccine.
    Sampliner RE
    Ariz Med; 1983 Jun; 40(6):416-8. PubMed ID: 6882237
    [No Abstract]   [Full Text] [Related]  

  • 14. Type B hepatitis: a review of current prospects for a safe and effective vaccine.
    McAuliffe VJ; Purcell RH; Gerin JL
    Rev Infect Dis; 1980; 2(3):470-92. PubMed ID: 6997970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatitis B vaccine: results of the Belgian clinical trials with 150 volunteers].
    Donéa-Debroise B; François-Gérard C; Sondag-Thull D; André A
    Rev Med Liege; 1982 Apr; 37(8):261-7. PubMed ID: 7048477
    [No Abstract]   [Full Text] [Related]  

  • 16. IgM antibody to hepatitis B core antigen as a diagnostic parameter of acute infection with hepatitis B virus.
    Lemon SM; Gates NL; Simms TE; Bancroft WH
    J Infect Dis; 1981 Jun; 143(6):803-9. PubMed ID: 6788859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral hepatitis.
    Alcoff J
    J Fam Pract; 1982 Jul; 15(1):141, 145-7, 151-4 in passim. PubMed ID: 6806432
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent developments in viral hepatitis.
    Friedman LS; Dienstag JL
    Dis Mon; 1986 Jun; 32(6):313-85. PubMed ID: 3009113
    [No Abstract]   [Full Text] [Related]  

  • 19. Non-A, maybe-B hepatitis.
    Feinstone SM; Hoofnagle JH
    N Engl J Med; 1984 Jul; 311(3):185-9. PubMed ID: 6429533
    [No Abstract]   [Full Text] [Related]  

  • 20. [Non-A, non-B hepatitis-related antigens and antibodies and experimental infection].
    Yoshizawa H
    Rinsho Byori; 1984 Nov; 32(11):1202-12. PubMed ID: 6084080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.